W.E.G. Müller, H.C. Schröder,Editors, ,Biological Response Modifiers - Interferons, Double-Stranded RNA and 2′5′-Oligoadenylates. Progress in Molecular and Subcellular Biology (1994) Springer-Verlag,Berlin, Heidelberg, New York (Eds.), Vol. 14. XV, 275 pages, 68 figures, Hardcover, DM 198.-.
- 作者A. Stelzner
- 卷第282卷
- 期第4期
- 印刷ISSN0934-8840
- 文件大小117.81KB
- 发表时间1995
- DOI10.1016/s0934-8840(11)80734-6
Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacinHector F. Bonilla; Lidija T. Zarins; Suzanne F. Bradley; Carol A. Kauffman · 1996
Susceptibility of ciprofloxacin-resistant Staphylococci and Enterococci to clinafloxacinGregory D. Harrington; Lidija T. Zarins; Mary A. Ramsey; Suzanne F. Bradley; Carol A. Kauffman · 1995
[Advances in Experimental Medicine and Biology] Neurobiology of Respiration Volume 788 || In Vitro Susceptibility of Staphylococci and Enterococci to Vancomycin and TeicoplaninPokorski, Mieczyslaw · 2013
Susceptibility of staphylococci and enterococci to antimicrobial agents at different ward levels in four north European countriesClaesson, Carina; Hällgren, Anita; Nilsson, Maud; Svensson, Erik; Hanberger, Håkan; Nilsson, Lennart E.; THE SCOPE STUDY GROUP, · Scandinavian Journal of Infectious Diseases · 2007
Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centresBarry, A. · Journal of Antimicrobial Chemotherapy · 1998
In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptidesCercenado, E. · Journal of Antimicrobial Chemotherapy · 2003